Table 1.
Vaccine | Route of administration | Dose | Dose volume |
---|---|---|---|
saRNA (formulated in LNPs, PNPs or SLNs) | IM | 0.15 μg | 50 μL |
ID | 0.15 μg | 20 μL | |
IN | 1.5 μg | 50 μL | |
Rabipur | IM | 2% HD | 50 μL |
ID | 2% HD | 20 μL | |
IN | 5% HD | 50 μL |
saRNA: self-amplifying RNA; LNPs: lipid nanoparticles, PNPs: polymeric nanoparticles; SLNs: solid-lipid nanoparticles; IM: intramuscular; ID: intradermal; IN: intranasal; HD: human dose.